← Evidence map

ArticleFrontiers in oncology2022

DIRAS2 Is a Prognostic Biomarker and Linked With Immune Infiltrates in Melanoma.

Wenli Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35651810